Personalised medicine

New research suggests the genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress.

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.

Our scientists are working to improve brain tumour diagnosis. Find out how this could make treatment more personal, and guide people onto clinical trials.

New research has shown that an intelligent knife can distinguish between ovarian cancer and normal tissue. Could it help make ovarian cancer surgery smarter?

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.

Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.

Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.

Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.

New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.